Cipla
Anshika Singh is currently serving as a Quality Control (QC) professional at Cipla since December 2023. Prior to this role, Anshika worked as an Executive in both Quality Assurance and Quality Control at Jeeva Organic Private Limited from February 2023 to December 2023. Anshika is pursuing a Bachelor of Pharmacy (BPharm) in Pharmaceutical Sciences at Siksha 'O' Anusandhan University, with enrollment starting in 2019. Anshika received education at DBMS Kadma High School in India.
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.